DALLAS, Texas — June 28, 2018 — Susan G. Komen®, the world’s leading breast cancer organization, today welcomed five new members to its Board of Directors. These respected leaders bring expertise in technology, finance, marketing and medicine, as well as a deep commitment to philanthropy and the fight against breast cancer. The organization also appointed a new Chairman of the Board of Directors, Peter D. Brundage.
Brundage has served on Komen’s Board of Directors since 2017, and succeeds Past Chair Connie O’Neill who will remain on the Board as a member. Brundage brings more than three decades of knowledge in finance, mergers and acquisitions, and corporate governance, as well as vast philanthropic engagement in the Dallas/Fort Worth area.
“We are truly delighted by the talent and experience that these new members bring to Komen’s Board, and look forward to their contributions as we work to reduce breast cancer deaths and ultimately end this disease,” said Brundage.
The new members, voted in unanimously in June are:
Kaye Ceille – Senior Vice President, Avis Budget Group. Ceille brings nearly two decades of experience in senior leadership positions in the travel and transportation industry, including international operations, global partnerships and business development. Ceille received a Bachelor of Business Administration degree from St. Norbert College in De Pere, Wisconsin, and an Master of Business Administration from Loyola University in Chicago. Ceille is a cancer survivor who is active in cancer organizations, including past experience on Komen’s Board of Directors.
Michael B. Greenwald – Senior Vice President, Tiedemann Advisors. Greenwald brings a passion and dedication to serve on behalf of the United States and others, spending almost a decade with the U.S. Treasury Department. Greenwald also devotes his personal time to humanitarian, and philanthropic efforts, including the fight against breast cancer serving as the international advisor to Dana Farber Cancer Institute President Laurie Glimcher, and the United States Holocaust Museum board. Prior to joining Tiedemann, Greenwald worked in senior diplomatic roles within the U.S. government, serving as a financial diplomat in Africa, Europe, and the Middle East. Greenwald is a Visiting Fellow at Harvard Kennedy School’s Belfer Center for Science and International Affairs and an Adjunct Professor at Boston University Pardee School of Global Studies. Greenwald earned a Juris Doctor degree from Boston University School of Law, a Master of Arts from Boston University’s Frederick S. Pardee School of Global Studies, and a Bachelor of Arts in History from George Washington University.
Dr. Doug Knutson – Chief Academic Officer, OhioHealth. With 25 years of clinical experience, Dr. Knutson works to educate patients and caregivers, support biomedical research, and improve health care delivery systems. For six years, he has served on the Susan G. Komen Columbus Affiliate Board of Directors, including two years as Board President, and now joins Komen’s National Board of Directors as Affiliate Representative. Dr. Knutson received a Bachelor of Science from Miami University in Oxford, Ohio, and his M.D. from The Ohio State University College of Medicine.
Kristin Nimsger – Chief Executive Officer at Social Solutions, a performance management software company. A proven leader, Nimsger brings vast experience in technology, marketing, fundraising and organizational strategy, and a desire to empower women and improve outcomes. Nimsger received a Bachelor of Arts from the University of Minnesota, and a Juris Doctor from William Mitchell College of Law.
Stephanie Stahl – Founder of Studio Pegasus, an angel investment and digital start-up advisory company. Stahl has held leadership roles at well-known and respected brands including Chief Global Marketing and Strategy Officer at Coach, and Executive Vice President and Chief Marketing Officer at Revlon. Stahl was previously a Partner at The Boston Consulting Group. With a broad range of experience and skills, and a deep personal connection to the cause, Stahl brings to Komen expertise in strategy development, governance, marketing, finance and more. Stahl received a Bachelor of Arts from Stanford University and a Master of Business Administration from Harvard Business School.
Board terms for Jane Abraham, Alan Feld, Janet Frantz, Dan Glennon, Melissa Maxfield and Dr. Funmi Olopade have ended, but each remains committed to Komen’s mission and will continue to partner with the organization to support breast cancer programs worldwide.
“The commitment each of our Board members makes not only to guiding and strengthening this organization, but to helping us save lives and achieve our mission, cannot be understated. We are grateful to each person who has served on our Board, and look forward to continuing to work together to end breast cancer,” added Brundage.
About Susan G. Komen®
Susan G. Komen is the world’s largest breast cancer organization, funding more breast cancer research than any other nonprofit outside of the federal government while providing real-time help to those facing the disease. Komen has set a Bold Goal to reduce the current number of breast cancer deaths by 50 percent in the U.S. by 2026. Since its founding in 1982, Komen has funded more than $956 million in research and provided more than $2.1 billion in funding to screening, education, treatment and psychosocial support programs serving millions of people in more than 60 countries worldwide. Komen was founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life. That promise has become Komen’s promise to all people facing breast cancer. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at ww5.komen.org/social.